Experiments revealed that depletion of cathepsin S in tumors leads to reduction of CCL2 and tumor-associated macrophages, demonstrating the roles of cathepsin S in altering the cellular constitution of the TME and driving tumorigenesis [33]. The gene discussed is CCL2; the disease is neoplasm.